Moderna said Friday that Pfizer and BioNTech's vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax.
The findings reflect the changing nature of the pandemic, in which the vast majority of people already have some protection against the virus due to vaccination or prior infection.
Researchers say exploiting that weakness could pave the way for new treatments that would be effective against all strains of the illness that has killed almost 6.5-million people across the globe since it was identified more than two years ago.
There has traditionally been a barrier to community pharmacists being engaged in research. I have worked to overcome this barrier. We are on the frontlines. What we do is practise, and this has real-world applications.